(Q40647738)

22 September 2017

Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis (English)

1 reference

oral squamous cell carcinoma

22 September 2017

1 reference

1

0 references

Takashi Takata

series ordinal

6

object named as

Takashi Takata

1 reference

22 September 2017

4

Mutsumi Miyauchi

1 reference

22 September 2017

5

Ikuko Ogawa

1 reference

22 September 2017

Shojiro Kitajjma

2

1 reference

22 September 2017

Sunao Sato

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

22 September 2017

6

1 reference

inferred from page(s)

published in

Oral Oncology

1 reference

22 September 2017

39

1 reference

22 September 2017

515-520

1 reference

22 September 2017

5

1 reference

A genetic model for colorectal tumorigenesis

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Many gene changes found in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

1 reference

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Reduced expression of p27(Kip1) correlates with an early stage of cancer invasion in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900015-0

7 January 2021

10.1016/S1368-8375(03)00015-0

Identifiers

DOI

1 reference

release_pqtdpoy5nfcmbnqwsasloc6e3u

22 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pqtdpoy5nfcmbnqwsasloc6e3u

24 November 2022

mapped directly with Wikidata item

1 reference